NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
- NHS England
Procurement identifier (OCID): ocds-h6vhtk-05cf3b
Description
Project title: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026
Offer reference number: CM/TNS/25/5737
Period of framework: 1 April 2026 to 31 March 2028 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Notices
UK4: Tender notice
- Notice identifier
- 2025/S 000-085570
- Published
- 22 December 2025, 4:55pm
UK2: Preliminary market engagement notice
- Notice identifier
- 2025/S 000-066480
- Published
- 17 October 2025, 4:37pm